General Information of the Compound
Compound ID
CP0514483
Compound Name
(6aR,9S,11S,12aS,12bS)-9-hydroxy-11-methyl-1,2,3,5,6,6a,8,9,10,11,12a,12b-dodecahydrochromeno[2,3-g]indolizin-12-one
    Show/Hide
Synonyms
BDBM50269339
CHEMBL509995
Grandisine C
    Show/Hide
Structure
Formula
C16H23NO3
Molecular Weight
277.364
Canonical SMILES
C[C@H]1C[C@H](O)CC2=C1C(=O)[C@H]1[C@@H]3CCCN3CC[C@H]1O2
    Show/Hide
InChI
InChI=1S/C16H23NO3/c1-9-7-10(18)8-13-14(9)16(19)15-11-3-2-5-17(11)6-4-12(15)20-13/h9-12,15,18H,2-8H2,1H3/t9-,10-,11-,12+,15-/m0/s1
    Show/Hide
InChIKey
WNDBXOYUMYCREE-NAYUARGSSA-N
Physicochemical Property
logP
1.4835
Rotatable Bonds
0
Heavy Atom Count
20
Polar Areas
49.77
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
20

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 16086540
SID: 24732478
ChEMBL ID
CHEMBL509995
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01200, Delta-type opioid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 14600 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Grandisine C )
Drug Name Grandisine C
Target(s)
Opioid receptor delta (OPRD1)
Inhibitor